Literature DB >> 3977913

Primary structure of the variable region of an amyloidogenic Bence Jones protein NIG-77.

H Tonoike, F Kametani, A Hoshi, T Shinoda, T Isobe.   

Abstract

The complete amino acid sequence of the variable region of a Bence Jones protein NIG-77 from an individual with myeloma-associated systemic amyloidosis has been determined. This protein represents a complete light chain consisting of 216 residues and it has a sequence characteristic of V lambda I subgroup, which is closely homologous to that of another amyloidogenic V lambda I Bence Jones protein NIG-51, differing by 20 of 111 residues (82% homology). In contrast, it differs by 29 residues (74% homology) to that of non-amyloidogenic V lambda I light chain NIG-64. This finding shows that, in accordance with our previous report(1), the V lambda I-related light chains can further be divided into two distinct subsubgroups, V lambda I-1 and V lambda I-2, and the latter property seems to be more prone in association with the amyloid process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977913     DOI: 10.1016/0006-291x(85)90317-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.

Authors:  E Holm; K Sletten; G Husby
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

4.  Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

Authors:  P Aucouturier; A A Khamlichi; J L Preud'homme; M Bauwens; G Touchard; M Cogné
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.

Authors:  P W Stevens; R Raffen; D K Hanson; Y L Deng; M Berrios-Hammond; F A Westholm; C Murphy; M Eulitz; R Wetzel; A Solomon
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.